# Reviva Pharmaceuticals Holdings, Inc.: Form DEF 14A, filed Oct 28, 2024

- Company: [Reviva Pharmaceuticals Holdings, Inc.](/companies/rvph.md) (CIK 1742927)
- Form: DEF 14A
- Filed: 2024-10-28
- Accepted by EDGAR: Oct 28, 2024, 16:17 ET
- Period: 2024-12-10
- Accession: 0001437749-24-032297
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1742927/000143774924032297/rvph20241023_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1742927/000143774924032297/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1742927/000143774924032297/rvph20241023_def14a.htm

Filed Oct 28, 2024.
Source: SEC EDGAR, the filing index for accession 0001437749-24-032297. Last ingested by Listed: Oct 29, 2026, 16:33 ET. No prices; not investment advice.